Exploratory trial of a combination therapy of Gemcitabine, S1 and immunotherapy against pancreatic cancer.
Phase of Trial: Phase I
Latest Information Update: 02 Jun 2017
At a glance
- Drugs WT1-W10 peptide vaccine (Primary) ; Gemcitabine; Gimeracil/oteracil/tegafur
- Indications Pancreatic cancer
- Focus Adverse reactions
- 02 Jun 2017 New trial record